Home » Topics » Regulatory

Regulatory
RSS

Effexor XR receives FDA approval for treatment of GAD

March 15, 1999

FDA okays new indication and minimal liver function testing for Lescol

March 12, 1999

Repligen to develop novel treatment for autism; clinical trials slated to begin this year

March 11, 1999

FDA approves new therapy for type II diabetes

March 10, 1999

FDA approves controlled-release form of popular antidepressant

March 8, 1999

Bupropion more effective than nicotine patches in smoking cessation therapy

March 8, 1999

Novartis obtains first western approval for new antimalarial drug combination

March 4, 1999

Pfizer claims new, improved compositions of alatrofloxacin

March 4, 1999

Glaxo Wellcome seeks approval for Zyban in the E.U.

March 4, 1999

Australian patent issued for oral form of paclitaxel

March 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 19, 2025.
Skyhawk’s small-molecule RNA efforts draw Merck KGaA in $2B deal
BioWorld
Adding another name to an impressive roster of partners assembled over the past few years, Skyhawk Therapeutics Inc. inked a neurology-focused deal with Merck...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 19, 2025.
CSL to shave off 3,000 jobs, Seqirus vaccine unit
BioWorld
CSL Ltd.’s stock tumbled 16.88% on the news that it plans to cut 3,000 jobs and to hive off its Seqirus vaccine unit in a cost-cutting measure to save more than...
GI blow: Viking soldiers on with midstage oral obesity bid
BioWorld
Rates of adverse events (AEs) gave pause to some on Wall Street, and shares of Viking Therapeutics Inc. (NASDAQ:VKTX) fell 42%, or $17.73, to close Aug. 19 at...